Skip to main content

Vaccine surge, commodity price curbs

After a slow start, China’s COVID-19 vaccine rollout is now one of the world’s fastest and is currently responsible for over half of daily inoculations globally. At this pace, China could catch up with the developed world within a quarter or two and achieve herd immunity by year-end. This should support a further rebound in the service sector, which even in China is still being held back by the pandemic. Meanwhile, the State Council has called for further efforts to cap rising commodity prices. But with capacity already stretched and few signs of speculative activity, administrative tools will be of limited use. A drop in demand may do the job instead, as the withdrawal of last year’s stimulus weighs on construction activity.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.